UPDATE 7-Data on Gilead drug raises hopes in pandemic fight, Fauci calls it 'highly significant'
Thu, 30 Apr 2020 1:53:36 UTCNews Agency:
The top U.S. infectious disease
official said Gilead Sciences Inc's experimental antiviral drug
remdesivir will become the standard of care for COVID-19 after
early clinical trial results on Wednesday showed it helped
patients recover more quickly from the illness caused by the
Click here for FULL Story on Reuters